ASCO 2024: Artificial Intelligence and Deep Learning in Pros

ASCO 2024, Prostate Cancer, Prostate Cancer Pathology, Artificial Intelligence and Deep Learning in Prostate Cancer Pathology, TMPRSS2:ERG fusion status.

Related Keywords

Chicago , Illinois , United States , Canada , Georgia , American , Liang Cheng , Zachary Klaassen , Williamb Schwartz , Laboratory Medicine , Twitter , Lancet Commission On Prostate Cancer , Department Of Pathology , Brown University , American Society Of Clinical Oncology , Translational Research , Georgia Cancer Center , Warren Alpert Medical School , Clinical Oncology , Lancet Commission , Prostate Cancer , Gleason Scores , Gleason Grade Groups , New England Journal , Vice Chair , Anatomic Pathology , Molecular Pathology , Urologic Oncologist , Associate Professor , Annual Meeting ,